Lexington, MA, United States of America

Julia B Gershkovich

This inventor holds 1 USPTO granted patent. Top assignee: Genzyme Corporation. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julia B Gershkovich. Retrieved from https://idiyas.com/inventor/julia-b-gershkovich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 241(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Julia B. Gershkovich: Innovator in Hemostatic Compositions

Introduction

Julia B. Gershkovich is a notable inventor based in Lexington, MA (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of hemostatic compositions. Her innovative work has the potential to impact medical practices and improve patient outcomes.

Latest Patents

Julia holds a patent for "Compositions comprising hemostatic compounds and bioabsorbable polymers." This patent describes solid, fibrous bioabsorbable hemostatic compositions that contain a bioabsorbable polymer and a hemostatic compound. The patent also outlines methods for making and using these hemostatic compositions, showcasing her expertise in creating advanced medical solutions.

Career Highlights

Julia is currently employed at Genzyme Corporation, a leading biotechnology company known for its focus on rare diseases and innovative therapies. Her role at Genzyme allows her to further her research and development efforts in the biomedical field.

Collaborations

Julia has collaborated with Keith E. Greenawalt, enhancing her research capabilities and contributing to the advancement of their shared projects.

Conclusion

Julia B. Gershkovich is a pioneering inventor whose work in hemostatic compositions exemplifies innovation in the biomedical sector. Her contributions are poised to make a lasting impact on medical treatments and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…